课题基金 / 基金详情

小鼠卵子重构介导的生殖性半克隆研究

批准号:
82101802
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
梁丹
依托单位:
学科分类:
辅助生殖
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
梁丹

项目摘要

结项摘要

相似基金

相关文献

中文摘要
当前辅助生殖技术迅猛发展,但却无法使配子缺乏的夫妇获得自己遗传学上的后代。通过生殖性半克隆技术,即体细胞核移植技术获得克隆配子,与配偶正常配子结合生育自己遗传特征的后代是绝大多数患者夫妇的愿望,也是生殖医学的重大突破。项目申请人既往研究中首创性的建立了 “人造精子”介导的半克隆技术。然而,通过克隆卵子获得半克隆囊胚及动物研究尚未见报道。项目申请人基于既往研究基础,在预实验中实现领域突破,通过体细胞核移植技术获得克隆卵子,并在体外与正常精子受精,成功获得小鼠半克隆囊胚。本项目拟在预实验的基础上通过重编程因子促进体细胞重编程过程来建立更加高效的卵子重构生殖性半克隆技术并获得半克隆动物,同时构建胚胎干细胞系从基因组整倍性及表观遗传探究其安全性及有效性;从重构卵的纺锤体形成、同源染色体配对分离以及参与的关键蛋白和基因探索其发生机制。本项目的研究将会加深对配子发育的理解,为临床不孕治疗提供新的思路。
英文摘要
Currently, assisted reproductive technology (ART) develops rapidly. However, there is no way to sovle this problem for couples who lack for gametes. The clonal gametes obtained through somatic cell nuclear transfer (SCNT)can fertiled with normal gametes to give birth to offspring, namely reproductive semi-cloned technology, which can enable couples without gametes to give birth to offspring with their own genetic characteristics. It is desirable by majority of infertile couples and will be also a huge breakthrough in reproductive medicine. In previous research, the project applicant established "artificial sperm" mediated semi-cloning technology for the first time. The establishment, research and application of semi-cloned technology mediated by "artificial sperm" have been very mature and in-depth. However, the study of semi-cloned blastocysts or animal obtained by somatic cell egg reconstructed in vitro has not been reported yet. On the basis of previous research, we made a huge breakthrough in the field in the preliminary experiment by obtaining cloned eggs through somatic cell nuclear transfer technology, which was fertilized with normal sperm in vitro and successfully obtained mouse semi-cloned blastocysts. On the basis of the pre-experiment, this project intends to establish a more efficient reproductive semi-cloned technology for egg reconstruction and obtain semi-cloned animals by promoting the process of somatic cell reprogramming through reprogramming factors, and meanwhile, to construct embryonic stem cell lines to explore its safety and effectiveness from genomic euploidy and epigenetics. Moreover, we will further figure out the mechanism through spindle formation, homologous chromosome division of reconstructed egg genome and key gene in this process. This study will deepen the understanding of gamete development, provide a new idea for clinical infertility treatment, and have a profound impact on reproductive medicine.
当前辅助生殖技术虽取得突破,但配子缺乏夫妇仍难以生育自身遗传学后代,这一问题成为不孕治疗的重要挑战。本研究基于“人造精子”介导半克隆技术,通过体细胞核移植在小鼠模型中成功获得克隆卵子,并实现其与正常精子受精生成半克隆囊胚,为人工配子重构及辅助生殖技术提供了新思路。研究聚焦四方面:建立卵子介导的小鼠生殖性半克隆技术,实时观测重构胚胎发育过程,开发半克隆胚胎同源染色体分离检测方法,以及表观遗传全基因组测序技术评估安全性。本研究采用灭活仙台病毒融合技术替代传统Peizo破膜法,有效减少操作损伤。选用FVB/N纯合小鼠胚胎成纤维细胞作为供体,与去核MII期卵母细胞融合,并结合单精子卵胞浆注射(ICSI)完成受精,成功生成来源于体细胞单倍体的半克隆囊胚。结果显示,重构卵能够高效排出极体、完成同源染色体分离,其早期发育过程与正常ICSI胚胎高度相似。然而,将半克隆囊胚移植至假孕母鼠后未获活产个体,提示可能存在染色体异常或表观遗传失衡。通过EmbryoScope Time-lapse系统动态监测发现,与常规ICSI及传统SCNT相比,半克隆胚胎在雌雄原核形成、2-cell阶段等关键节点表现独特特点,如极体排放和染色体行为类似正常配子的ICSI过程。这为进一步优化伪减数分裂中的染色体行为提供依据。此外,本研究开发了一种基于单细胞全基因组扩增和AmpliSeq的新型测序方法,通过识别同源染色体上的SNPs精准解析伪减数分裂期间的染色体分离情况。同时,还建立微量表观遗传全基因组解析方法,以揭示DNA去甲基化中间产物5-羟甲基胞嘧啶(5hmC)的动态变化及功能特性。结果发现,5hmC对多能性维持、谱系选择及早期胚胎发育调控具有重要作用,为评估人工配子的表观遗传稳定性及提升重编程效率提供参考。综上,本研究系统构建了小鼠卵子重构介导的生殖性半克隆核心平台,在实验优化、新工具开发及机制探索方面取得重要进展,加深了对人工配子的发生、生殖潜能及安全性的理解,为解决配子缺乏导致的不孕问题开辟新方向,也为辅助生殖领域带来更多可能。
国内基金
海外基金